The US Food and Drug Administration (FDA) has granted 510(k) clearance to Zimmer Biomet's new revision knee implant component, Persona Revision SoluTion Femur, to provide an option for individuals ...
Zimmer Biomet Holdings, Inc (NYSE:ZBH) announced plans to phase out its CPT Hip System by December. The decision comes on the ...
March 7, 2025 /PRNewswire/ -- Zimmer Biomet Holdings ... clearance of Persona ® Revision SoluTion™ Femur, a revision knee implant component offering an alternative for patients with ...
The Persona Revision Knee System claims to “replicate” the anatomy of a person for an “individualised” fit across primary, partial, and revision knee arthroplasties. Zimmer’s implant is ...